Reduced Interleukin-17-Expressing Cells in Cutaneous Melanoma

Anna Tosi(University of Padua), Andrea Cavani(Istituto Dermopatico dell'Immacolata)

Biomedicines

December 16, 2021

10.3390/biomedicines9121930

Cited by 4

Related Papers

Interleukin‐17 and interleukin‐22 promote tumor progression in human nonmelanoma skin cancer

|European Journal of Immunology|2014|96

The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors

|Journal of Experimental & Clinical Cancer Research|2022|92